companies / alloytx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
Alloy Therapeutics, Inc. was listed in 8VC's portfolio, recorded 2026-09-30.
verified=2026-05-06 json
| total_raised | 30,020,25930.0M | ○ |
|---|---|---|
| founded | 2017 | |
| hq | Waltham, MA | |
| industry | unknown | |
| stage | null |
Alloy Therapeutics offers integrated drug discovery across antibodies, bispecifics, TCR mimics, genetic medicines, and cell therapy. It serves biopharma partners outsourcing computational design plus wet-lab validation. Differentiator: AI/ML predictive design fused with hands-on experimental execution.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-03-31 | Funding round | 30,020,25930.0M | null | ○ |
| investor | src |
|---|---|
| 8VC | ○ |
Cloudflare, WordPress, Typekit, Adobe Fonts, Metronet Profile Picture 2.6.3, Lucky Orange, Yoast SEO 27.4, Yoast SEO Premium 23.8, reCAPTCHA, Google Tag Manager, jQuery Migrate 3.4.1, Elementor 4.0.2
| fact | status | src |
|---|---|---|
| Funding round, $30.0M | attributed | ○ |
| Investor 8VC | sourced | WEB |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-30provenance_investor_8vc: unknown → sourced, WEB 2026-09-30 | provenance_investor_8vc | unknown → sourced | WEB 2026-09-30 |
| 2026-09-25latest_round: seed, $30.0M, 2026-03-31 → Funding round, $30.0M, 2026-03-31, ○ 2026-05-06 | latest_round | seed, $30.0M, 2026-03-31 → Funding round, $30.0M, 2026-03-31 | ○ 2026-05-06 |
Records begin 2026-09-24. all_changes